TY - JOUR
T1 - Mitral regurgitation progression following isolated coronary artery bypass surgery
T2 - Frequency, risk factors, and potential prevention strategies
AU - Campwala, Saida Zen
AU - Bansal, Ramesh C.
AU - Wang, Nan
AU - Razzouk, Anees
AU - Pai, Ramdas G.
N1 - Mitral regurgitation (MR) is common in patients with coronary artery disease and those undergoing coronary artery bypass surgery (CABG) [1, 2]. Behavior of significant MR grades and its response to CABG, has been studied and has been shown to regress with a reduction in left ventricular (LV) size [3].
PY - 2006/3
Y1 - 2006/3
N2 - Background: Though de novo mitral regurgitation (MR) is frequently seen in patients who have undergone coronary artery bypass surgery (CABG), its incidence, predictors, and mechanisms are not known. Methods: Our surgical registry was screened for patients undergoing isolated CABG who had preoperative and postoperative resting echocardiograms performed at our institution with ≤2+ MR preoperatively. This yielded 438 patients. Progression to 3-4+ MR post-CABG was correlated with clinical, electrocardiographic, echocardiographic, and operative variables. Results: New 3-4+ MR developed in 11 (10%) of the 108 patients with no prior MR, 21 of the 180 (12%) patients with pre-CABG 1+ MR, and 37 of the 150 (25%) patients with pre-CABG 2+ MR. MR progression correlated with female gender (42% vs 27%, p = 0.01), history of renal insufficiency (12% vs 5%, p = 0.05), prior-CABG (30% vs 17%, p = 0.01), lack of beta-blocker use (19% vs 35%, p = 0.008), lower incidence of significant PDA stenosis grafted (88% vs 98%, p = 0.003), lower preoperative LVEF (42 ± 19% vs 50 ± 17%, p = 0.001), larger LV size (p = 0.01), pre-CABG MR grade (p = 0.0002), and pre-CABG presence of LBBB block (20% vs 4%, p < 0.0001). Independent predictors of MR progression, pre-CABG, were female gender (p = 0.002), history of renal insufficiency (p = 0.05), lack of beta-blocker use (p = 0.006), MR grade (p = 0.02), and presence of LBBB (p = 0.005). Conclusion: Development of significant MR following isolated CABG is common and may be related to incomplete myocardium revascularization, especially in the PDA area and LV remodeling. Preoperative, beta-blocker use may be protective against its development. © 2005 Elsevier B.V. All rights reserved.
AB - Background: Though de novo mitral regurgitation (MR) is frequently seen in patients who have undergone coronary artery bypass surgery (CABG), its incidence, predictors, and mechanisms are not known. Methods: Our surgical registry was screened for patients undergoing isolated CABG who had preoperative and postoperative resting echocardiograms performed at our institution with ≤2+ MR preoperatively. This yielded 438 patients. Progression to 3-4+ MR post-CABG was correlated with clinical, electrocardiographic, echocardiographic, and operative variables. Results: New 3-4+ MR developed in 11 (10%) of the 108 patients with no prior MR, 21 of the 180 (12%) patients with pre-CABG 1+ MR, and 37 of the 150 (25%) patients with pre-CABG 2+ MR. MR progression correlated with female gender (42% vs 27%, p = 0.01), history of renal insufficiency (12% vs 5%, p = 0.05), prior-CABG (30% vs 17%, p = 0.01), lack of beta-blocker use (19% vs 35%, p = 0.008), lower incidence of significant PDA stenosis grafted (88% vs 98%, p = 0.003), lower preoperative LVEF (42 ± 19% vs 50 ± 17%, p = 0.001), larger LV size (p = 0.01), pre-CABG MR grade (p = 0.0002), and pre-CABG presence of LBBB block (20% vs 4%, p < 0.0001). Independent predictors of MR progression, pre-CABG, were female gender (p = 0.002), history of renal insufficiency (p = 0.05), lack of beta-blocker use (p = 0.006), MR grade (p = 0.02), and presence of LBBB (p = 0.005). Conclusion: Development of significant MR following isolated CABG is common and may be related to incomplete myocardium revascularization, especially in the PDA area and LV remodeling. Preoperative, beta-blocker use may be protective against its development. © 2005 Elsevier B.V. All rights reserved.
KW - CABG
KW - MR
KW - Severity of Illness Index
KW - Mitral Valve Insufficiency/diagnostic imaging
KW - Humans
KW - Middle Aged
KW - Risk Factors
KW - Male
KW - Adrenergic beta-Antagonists/therapeutic use
KW - Disease Progression
KW - Coronary Disease/complications
KW - Renal Insufficiency/complications
KW - Sex Factors
KW - Ultrasonography
KW - Electrocardiography
KW - Female
KW - Aged
KW - Retrospective Studies
KW - Coronary Artery Bypass/adverse effects
UR - https://www.scopus.com/pages/publications/32144459353
UR - https://www.scopus.com/pages/publications/32144459353#tab=citedBy
UR - https://www.mendeley.com/catalogue/b07c3399-65d4-3828-a00d-93b44aada960/
U2 - 10.1016/j.ejcts.2005.12.007
DO - 10.1016/j.ejcts.2005.12.007
M3 - Article
C2 - 16442297
SN - 1010-7940
VL - 29
SP - 348
EP - 353
JO - European Journal of Cardio-thoracic Surgery
JF - European Journal of Cardio-thoracic Surgery
IS - 3
ER -